Cytovale

📍 San Francisco, United States🗓 Founded 2013👥 120 employees💰 Last funded Jul 2024
Biotechnology Research🌐 cytovale.com
Website LinkedIn
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale Subscribe to our newsletter: http://eepurl.com/huCdiH
7
Total investors
3
Early stage
1
Mid stage
0
Late stage
2013
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
4
Switzerland
1
United Kingdom
1
Investor activity2012–2024 · investors recorded per year
2012120131201412018120243
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cytovale?
Cytovale has 7 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Cytovale last raise funding?
The most recent investment in Cytovale recorded on gritt.io was in July 2024.
When was Cytovale founded?
Cytovale was founded in 2013.
What industry is Cytovale in?
Cytovale operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cytovale based?
Cytovale is headquartered in San Francisco, United States.